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Abstract: The approaches based on high-resolution analytical techniques, such as nuclear magnetic
resonance or mass spectrometry coupled to chromatographic techniques, have a determining role in
several of the stages necessary for the development of functional foods. The analyses of botanical
extracts rich in bioactive compounds is one of the fundamental steps in order to identify and quantify
their phytochemical composition. However, the compounds characterized in the extracts are not
always responsible for the bioactive properties because they generally undergo metabolic reactions
before reaching the therapeutic targets. For this reason, analytical techniques are also applied to
analyze biological samples to know the bioavailability, pharmacokinetics and/or metabolism of the
compounds ingested by animal or human models in nutritional intervention studies. In addition,
these studies have also been applied to determine changes of endogenous metabolites caused by
prolonged intake of compounds with bioactive potential. This review aims to describe the main types
and modes of application of high-resolution analytical techniques in all these steps for functional
food development.
Keywords: analytical techniques; analytical chemistry; chromatography; functional food; mass
spectrometry; nuclear magnetic resonance; metabolomics; phytochemicals
1. Introduction
In recent years, the interest in new food products (e.g., functional foods, nutraceuti-
cals or foods supplements) has been increased by food industry. This kind of products
is characterized by containing a high concentration of bioactive compounds which exert
beneficial effects on human health. Secondary plant metabolites represent an important
source of bioactive compounds used in the development of new functional ingredients in
the agri-food and pharmaceutical industries. Phenolic compounds are the most characteris-
tic example of bioactive compounds whose dietary intake has shown beneficial effects in
different pathologies, such as obesity, cancer, neurodegenerative or cardiovascular diseases,
among others [1–4].
For the functional food development, it is generally necessary to carry out several
stages or sub-studies in order to obtain the desired product. Some of these stages are
as follows: bioactive compound extraction, phytochemical characterization, compound
isolation, bioactivity assays, encapsulation techniques, functional food formulation, indus-
trial scaling, sensory evaluation and nutritional intervention assays [5–7]. Due to the fact
that phytochemical concentrations in plant matrices are generally lower than the doses
necessary to provide the beneficial effects, the purpose of the extraction step is the recovery
of bioactive compounds from plant sources, achieving their isolating and concentration.
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The phytochemical characterization step aims to assign chemical identity and/or quantify
concentrations of the compounds present in the plant matrices [8].
The development of a functional food is valueless if the phytochemicals are not stable
in the food matrix or if they are not absorbed throughout the digestive system. For these
reasons, the isolation/purification, the control of toxicity, the verification of the bioactivity
properties and the determination of the bioavailability and metabolism of the characterized
compounds, are also necessary stages for the development of functional products. In this
context, encapsulation methodologies have been developed in order to protect the bioactive
components in the food matrix as well as favor their absorption in the gastrointestinal
tract [9–11]. Finally, once a functional food has been formulated, its sensory properties,
the industrial scaling and the effect of its prolonged intake are studied before being placed
on the market.
High-resolution analytical techniques play an important role in several of these stages
of functional food development, especially phytochemical characterization of plant ex-
tracts [8] and the analysis of biological samples collected after nutritional intervention
studies [12–14]. The objective of these studies is to identify the metabolites originated
after the ingestion of certain compounds or foods that help to know the bioavailability as
well as metabolic reactions that the original compounds undergo in the organism after
being ingested. These studies are classified in acute and longitudinal intervention studies
depending on whether biological samples are taken just after a single intake or if after
consuming the product continuously over time.
The most used analytical platforms for these studies are nuclear magnetic resonance
(NMR) and mass spectrometry (MS). NMR provides advantages in terms of structural
elucidation and high precision in the quantification. In contrast, the main disadvantage of
NMR is its lower sensitivity compared to MS [15,16]. On the other hand, MS stands out for
its higher sensitivity and selectivity. Although there are applications that use MS by direct
infusion, the great potential of this technique is achieved when it is previously coupled to a
separation technique, such as liquid chromatography (LC), gas chromatography (GC) or
capillary electrophoresis (CE), allowing the detection of hundreds of metabolites thanks
to lower ionic suppression and reduced sample complexity [17–19]. This review aims to
summarize the main modes of application of these analytical techniques in the different
steps of the development of functional foods. Mainly, this review focuses on the application
of these analytical techniques in phytochemical characterization and in the development of
nutritional intervention studies.
2. Phytochemical Characterization of Bioactive Compounds
The characterization of complex extracts from natural sources consists in assigning the
chemical structure as well as quantifying the concentration levels of the phytochemicals
present in them. The exhaustive information of the phytochemical profile of natural
matrices allows the discovery of new compounds, such as potential bioactive compounds
or toxic compounds, providing a better knowledge of health effects and ensuring greater
food safety, respectively. For that purpose, NMR, LC–MS and GC–MS have been the most
used analytical platforms to achieve qualitative and quantitative characterization of plant
extracts [19].
2.1. Mass Spectrometry (MS)
Mass spectrometry is based on the vacuum separation of ions in the gas phase accord-
ing to their mass/charge ratio (m/z) [19]. It is important to note that there is a constant
improvement in MS technology and new analytical approaches are being developed with
access to numerous spectral databases. In detail, MS consists of three phases: ionization,
mass analysis and detection. The molecular ions are produced in an ionization source.
These ions are transferred to the mass analyzer, which separates them according to their
m/z values. Then, the isolated ions reach the detector and finally the results are showed
as a mass spectrum [20]. To this end, different mass analyzers can be employed such as
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single quadrupole (Q), triple quadrupole (QQQ), quadrupole ion trap (QIT), time of flight
(TOF) and quadrupole-time of flight (QTOF). Among them, the high-resolution MS (HRMS)
analyzers, such as TOF or orbitrap, have a greater applicability in characterization studies
of bioactive compounds. The HRMS analyzers provide a precise relative quantification as
well as exact mass values with an accuracy of less than 5 ppm. In addition, these analyzers
also provide information about the isotopic distributions of chemical species, which is
useful along with the exact mass data for the generation of molecular formulas that are
useful to identify compounds [21]. On the other hand, tandem mass analyzers (MS/MS),
such as QTOF, QIT or QQQ, provide fragmentation patterns of precursor ions that are
of great application for metabolite identification and isomer resolution. As mentioned
above, MS is usually coupled to separation techniques such as LC and GC with the pur-
pose of improving the chemical characterization of phytochemicals contented in botanical
sources. The following subsections detail the main applications of LC–MS and GC–MS in
phytochemical characterization studies.
2.1.1. GC–MS
Gas chromatography (GC) is an analytical technique whose objective is the separation
of chemical compounds present in a complex matrix based on their volatilities and the
interactions with a stationary column. GC–MS provides a robust analysis that allows the
identification of analytes based on the comparison of the MS spectra with those available
in GC–MS libraries. This hyphenated technique has been mainly used for characterization
of low-molecular weight and medium or low polarity compounds, in particular, primary
metabolites such as fatty acids, carbohydrates, amino acids and all volatile compounds [22].
A condition for GC analyses is that the analytes must be volatile enough to be able
to be separated and detected. For this reason, many of the GC applications have been
based on the characterization of the volatile compounds fractions of different plant or food
matrices [23–25]. However, several non-volatile compounds can be derivatized prior to
analysis in order to increase its volatility. Thus, a well-chosen derivatization procedure,
based on the chemical composition of the target compounds, is crucial for improving the
chemical separation, being the conversion of the analyte to its trimethylsilyl derivative,
one of the most common derivatization methods [26,27]. This step is essential for non-
volatile plant secondary metabolites such as phenolics, terpenoids, steroids and alkaloids.
Electron ionization (EI) and chemical ionization (CI) are the common ionization meth-
ods in GC–MS while Q, QQQ, TOF and Q-TOF are the most widely used mass analyzers.
GC–TOF affords fast scanning, high sensitivity and mass accuracy compared to common
quadrupole (GC-Q). However, GC–EI–Q–MS is the most widely used configuration due
to its robustness, relatively low cost and the possibility of using libraries databases for
compound identification, which is one of the main advantages of using an EI source [22,28].
Since EI is a hard ionization source, this platform offers robust information relative to
fragmentation patterns of volatile compounds. The MS spectra are compared with the MS
libraries, allowing the identification of the analytes such as phytosterols, terpenes or fatty
acids that belongs to essential oils fraction of plants. Hence, numerous secondary metabo-
lites from botanical samples have been identified and quantified by GC–MS. As shown in
Table 1, GC–MS is able to determine the volatile fraction of plant sources.
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Table 1. Applications of GC–MS to characterize bioactive compound from natural sources.
MS
Detector GC Column Gradient (
◦C) CompoundsDetected Matrix Ref.
TOF
DB-5 MS (30 m) 60 to 300 (multistep increase) Terpenes Curcuma species [29]
BPX5 (30 m) 40 to 270 (4 ◦C/min) Essential oils Rosmarinus officinalis [30]
Q
RTS volatile (30 m) 70 to 280 (5 ◦C/min) Organic sulfur compounds Allium sativum [31]
HP-88 (100m) 70 to 230 (10 ◦C/min) Essential oils Lippia citriodora [32]
RESTEK
Rtx®-5 (30 m) 70 to 320 (7
◦C/min) Essential oils andderivatives Allium cepa [33]
SUPELCOWAX
10 (30 m)
60 to 240 (4 ◦C/min)
40 to 240 (multistep increase) Essential oils Camellia sinensis [34]
HP-5MS (30 m) 50 to 280 (multistep increase) Essential oils Curcuma species [35]
DB-1MS (60 m) 50 to 180 (2 ◦C/min) Essential oils and hydrosols Rosmarinus officinalis [36]
SUPELCOWAX
10 (30 m) 50 to 200 (5
◦C/min) Essential oils Rosmarinus officinalis [37]
QQQ HP-5MS (30 m) 80 to 300 (multistep increase) Essential oils Curcuma longa [38]
Q-TOF
HP-5MS (30 m) 250 to 310 (multistep increase) Triterpenoids Olea europaea [39]
HP-5MS (30 m) 250 to 310 (10 ◦C/min) Phytosterols and
Tocopherols Mangifera species [40]RTX-200MS (30 m) 250 to 310 (10 ◦C/min)
2.1.2. LC–MS
High performance liquid chromatography (HPLC) is a fast, versatile, reliable and
efficient technique capable of separating components from a complex liquid mixture.
LC involves a huge versatility regarding stationary and mobile phases [41]. Among
the different LC configurations, reverse-phase (RP) mode has been the most used in the
characterization of plant extracts. This RP-LC consists of a polar mobile phase and a
hydrophobic stationary phase. Specifically, C18 columns are generally the most commonly
used in this chromatographic mode. Different parameters (e.g., flow rate, type of column,
particle size, mobile phase, gradient, temperature, etc.) have to be correctly optimized in
an LC method to achieve a correct chemical separation. In recent years, ultra-high pressure
liquid chromatography (UHPLC) is being used more for the analysis of complex samples,
since it allows reaching higher pressures, allowing the use of columns with smaller particle
sizes (<2 µm), and therefore achieving a higher chromatographic resolution [42,43].
LC–MS platforms are more suitable for characterization of non-volatile compounds
with higher polarity and/or molecular weights. For example, flavonoids are generally
present in their glycosylated form in plant sources, involving a high number of hydroxyl
groups and higher molecular weights. Therefore, these intact glycosides are preferably
analyzed by LC–MS [44].
The speed, sensitivity and resolution are improved in UHPLC methodologies. An-
other advantage of UHPLC is the significant reduction of analysis time, which also implies
a reduction in solvent consumption [45]. Unlike GC, LC lacks a database library. Con-
sequently, the identification of analytes is a more difficult task. In this sense, MS/MS
analyzers, such QTOF, provide detailed information about characteristic fragments of
bioactive compounds that facilitate the phytochemical characterization. The potential of
these MS detectors covers the identification of a wide variety of polar and semi-polar
compounds such as sugars, terpenes or phenolic compounds, among others [46]. Thus,
as shows Table 2, LC coupled to different MS detectors is able to separate and to discern
the phytochemical composition of botanical sources.
Despite the great advantages of MS coupled with chromatographic techniques, these
methods still have limitations for obtaining the complete phytochemical characterization.
These limitations are related to the resolution of isomers that present similar retention times
and m/z ratios [47]. These limitations seem to have been overcome in recent years thanks to
an additional coupling of ion mobility spectrometry (IMS) [48]. IMS has become the most
valuable analytical technique for the analysis of complex mixtures, because it allows the
discrimination of species that are neither separated by chromatography nor by MS. Thus,
IMS is able to discriminate molecules with similar behaviors such as isomers, enantiomers,
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isobaric molecules and resolve isoforms and conformers. Therefore, the orthogonality of
LC, IMS and MS provide instruments that, when combined, offer an enormous resolution
capacity for increasing the level of coverage in the separation, identification of exact masses
and quantification of components of complex samples such as botanical extracts. Although
LC–IMS–MS is a recently emerging platform, some studies have already used it for plant
extracts characterization. For instance, thirteen alkaloids from Peganum harmal L. or lignans
from Schisandra chinensis oil were determined by HPLC–ESI–IMS–MS [49,50].




Detector Column Ionization Mode Compounds Detected Matrix Ref.
HPLC
TOF
Zorbax Eclipse Plus C18 Negative Organic acids, phenolicacids and flavonoids Hibiscus sabdariffa [51]
RP18 Negative Flavonoids, terpenoids Rosemaryofficinalis [52]





Quadrupole Eclipse XDB C18 Positive Anthocyanins Allium cepa [54]
Phenomenex Luna C18 Negative
Phenolic acids and
flavonoids Curcuma longa [55]










Zorbax Eclipse Plus C18 Negative Flavonoids Theobroma cacao [58]





Zorbax Eclipse Plus C18 Negative
Secoiridoids, flavonoids
and related compounds Olea europaea [60]
Qtrap Waters Spherisorb S3ODS-2 C18












Acquity UHPLC BEH C18 Positive Valifenalate Vitis vinifera [63]
Acquity HSS T3 Positive andnegative Hydroxycinnamic acids Vitis vinifera [64]
Acquity UPLC shield


















ACQUITY UPLC HSS T3 Negative Procyanidin Theobroma cacao [68]
Hypersil Gold Negative Terpenes, flavonoids,phenolic acids
Rosemary
officinalis [69]




gallates Camellia sinensis [70]








Zorbax SB-C18 Negative Stilbenes Vitis Vinifera [72]
2.2. NMR
NMR was originally employed in the late 1940s to determine the structure of molecules
in organic chemistry, but its application in food field was deferred until the 1980s. Nowa-
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days, a large number of NMR-food studies have been developed such as food quality
analysis, food composition or the metabolic profiling of medicinal plants [15,73–75].
Although NMR is not the best technique for phytochemical characterization due to
its relatively low sensitivity compared to MS, it has also been used in various studies for
the characterization of phytochemicals, such as phenolic compounds, in complex mix-
tures. For example, the polar fraction of virgin olive oil that contains several phenolic
compounds was analyzed by this technique. The identification of the olive oil pheno-
lic compounds was built on the chemical shifts of a large number of model compounds
assigned by NMR. Thus, this methodology was successful in detecting simple phenols,
such as vanillic acid, p-coumaric acid, vanillin, homovanillyl alcohol, free hydroxytyrosol
and free tyrosol, the flavonols apigenin and luteolin, the lignans (+) 1-acetoxypinoresinol,
(+) pinoresinol, (+)and syringaresinol, the dialdehydic form of oleuropein and ligstro-
side lacking a carboxymethyl group, two isomers of the aldehydic form of oleuropein
and ligstroside, and total hydroxytyrosol and total tyrosol reflecting the total amounts
of free and esterified hydroxytyrol and tyrosol, respectively [76]. In a more recent study,
the polyphenols profile in olive oils was analyzed by Maximum-Quantum (MaxQ) NMR
spectroscopy [77]. Three Italian olive oils were analyzed in which 24 compounds including
organic phenols, lignans, secoiridoids and flavonols were identified. In addition, this ap-
proach managed to show phenolic compound profiles with significant differences in the
three Italian olive oils analyzed.
NMR has been also applied to evaluate the composition changes of black garlic during
a thermal treatment [78]. In this study, 1H NMR spectra showed that 38 compounds were
altered by thermal procedure of raw garlic. Multivariate analysis reported changes in the
contents of glucose, amino-acids, formic acid, fructose, acetic acid, cycloalliin, pyroglu-
tamic acid, and 5-(hydroxymethyl)furfural. In another study, the green tea composition
was analyzed during a fermentation processing by 1H NMR and multivariate statistical
analysis [79]. 14 compounds including glucose, epigallocatechin, epicatechin, caffeine,
alanine, epicatechin-3-gallate, theanine, acetate, quinate, glutamate, sucrose, or gallate
were highlighted to be responsible for metabolic differentiation between green tea and fer-
mented tea. For example, the levels of epigallocatechin, epicatechin, epicatechin-3-gallate,
quinate, epigallocatechin-3-gallate, sucrose and caffeine decreased whereas glucose and
gallate levels increased after this process. NMR technology has also been used to classify
sample varieties according to their geographical origins. For instance, the chemical profile
of white wines produced from “Greco bianco” grape variety in different Italian areas were
determined by NMR [80].
One of the main advantages of NMR is its capacity for structural elucidation. This makes
it a technique of special interest when identity cannot be characterized by MS, as in the
case of isobaric compounds. For this reason, NMR has been applied for the analysis of
previously isolated fractions using chromatographic techniques such as semi-preparative
HPLC, column chromatography with silica gel, high speed counter-current chromatogra-
phy (HSCCC) among others LC platforms [81–83]. For example, numerous studies use
LC-NMR for the characterization of phenolic compounds. These examples include the
identification of gallic acid, protocatechuic acids and anthocyanins from Hibiscus sabdariffa
calyces [82,84], flavonoids from Lippia gracilis [85], procyanidins from cacao beans [86], epi-
catechin vanillate from grape seed and red wine [87], terpenoid glycosides from Rosmarinus
officinalis L. [88], and flavonols and phenolic acids from red onion peels [89].
3. Nutritional Intervention Studies
Despite the fact that natural or dietary bioactive compounds receive enormous atten-
tion due to their potential health benefits, there is still a lack of knowledge in the assessment
of their dietary intake. Although their bioactivities have been well-described by in vitro
models, these effects verified by in vivo models are still limited. In this sense, inconsistent
and low systemic exposure or poor oral bioavailability greatly limits the therapeutic uses
of these bioactive compounds [90]. For this reason, it is necessary to develop accurate
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approaches that provide an understanding of the factors related to bioavailability. Con-
sequently, bioavailability studies allow to know which bioactive compounds are able to
reach the bloodstream and the target tissue, where they can exert their biological activities.
In recent years, studies on the metabolism of bioactive compounds have been in-
creased considerably. However, data as doses, study organisms and time scales used in
experimental studies are inherently difficult to search for and place into context. The nutri-
tional intervention assays aim to know the effects on the organism of the consumption of
a certain product (nutrient, bioactive compound, food extract, food, dietary supplement,
diet, etc.). These types of studies are mainly classified into two groups depending on the
time of the intervention. On the one hand, acute intervention trials investigate the effects
of intake during the hours immediately after it, up to a maximum of 48 h. This group
includes studies of absorption, pharmacokinetics, bioavailability or metabolism of ingested
compounds. On the other hand, chronic or longitudinal nutritional intervention studies
focus on the effect that the intake of that substance, food or diet under study causes in the
body, prolonged over time, for weeks, months or years [91]. Moreover, the availability of
“omics” technologies gives the possibility for exploring pharmacological actions of single
and multi-compound formulations for the treatment of multifactorial disorders such as
cancer, diabetes, cardiovascular and aging-associated diseases. To understand the impact
of the bioactive compounds on human health, it is essential to establish the mechanisms
providing the information about the factors that depend on their bioavailability after intake.
These aspects are mentioned in the following subsections.
3.1. Acute Intervention Studies: Bioavailability and Pharmacokinetics
Bioavailability is defined as the fraction of an ingested ingredient that is bioaccesible,
absorbed, and able to reach the circulatory system to be distributed to organs and target
tissues where it can exert its health benefits. Several factors that affect the bioavailability of
a certain compound have been described, such as dose, synergistic effects, matrix release
and transport in the body or excretion. Since biological properties of dietary bioactive
compounds depend on their bioavailability, different in vivo studies have been reported
to measure their concentrations in plasma and urine after the intake of isolate bioactive
compounds, extracts or foods [92,93].
Numerous human and animal models have been used to evaluate the pharmacokinet-
ics and bioavailability of phenolic compounds. These types of studies have been carried out
thanks to the potential of high-resolution analytical techniques. Given the high resolution
and sensitivity of these techniques, there are many applications for the analysis of biological
samples, allowing the identification and/or quantification of bioavailable compounds in
low concentrations. Among them, LC–MS methods have been the most widely used for
bioavailability and pharmacokinetic studies in recent years [66,94–105].
For the development of functional foods, bioavailability studies should be ideally
performed in vivo on humans, but this is not always ethically and financially possible.
However, animal studies are necessary to provide knowledge about uptake and distribution
of bioactive compounds in body tissues, which are important factors for the evaluation of
the biological activity. Figure 1 shows the common procedure for acute intervention studies
using animal or human models. Both types of assays are characterized by the collection
of biological samples throughout the hours after the intake of the compounds of interest.
The main difference between both assays lies in the major possibilities of biological sample
collection in case of animal models. Regarding tissues, heart, liver, spleen, lung, kidney,
stomach, intestine, brain, muscle, adipose, testis or ovary have been explored in different
bioavailability studies in animal models [100,102,104].
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Figure 1. Scheme of a typical acute intervention study carried out in animal and human models.
Regarding the bioavailability of phenolic compounds determined by in vivo models,
total polyphenol intake detected in biological samples has been only estimated at 1–10% be-
ing significantly low for flavones as quercetin and rutin (0.3–1.5%), but higher for flavanols
(tea catechins), flavanones (naringenin from citrus fruits), soy isoflavones (genistein) and
red wine anthocyanidins (3–30%) [106]. In this context, there are recent studies which use
validated analytical methods to determine the bioavailability and pharmacokinetic param-
eters. For instance, Zeng et al. studied different parameters related to pharmacokinetics,
tissue distribution, metabolism, and excretion of naringin in aged rats [100]. In this study,
LC–QQQ–MS/MS method was applied for the quantification of naringin and naringenin in
plasma, urine, feces, and various tissue samples. In addition, 39 flavonoid metabolites and
46 microbial-derived phenolic catabolites could be identified by UHPLC-Q-TOF analysis.
They detected significant differences between the pharmacokinetic parameters between
female and male aged rats. Tissue distribution profiles at different time points showed
that the distribution of naringin and its metabolite after single oral dose was higher in
gastrointestinal tract and major organs, with the major concentration at 3 h and 6 h, respec-
tively [100]. Tao et al. developed a robust UHPLC–MS/MS method for the simultaneous
determination in rat plasma of cinnamic acid, vanillic acid and protocatechuic acid from
Cinnamomum cassia. They showed that the maximum concentration in plasma was obtained
one hour after oral administration [96]. In addition, this approach was applied for the
quantification of seven catechins in rat plasma [95]. This method was also applied by
Chang et al. for the determination and quantification of mangiferin, single Anemarrhenae
Rhizoma extract and multiple botanic extract of Suan-Zao-Ren decoction (SZRD) in rat
plasma [107]. Zhang et al. also verified that this UHPLC–MS/MS method is suitable for
the separation and simultaneous determination of two bioactive compounds (angoroside
C and its metabolite ferulic acid) in biological samples from rats [104].
Nevertheless, a key element that must be taken into account by researchers is the
concept of extrapolation of dose between species when new animal or human models are
designed. Nair and Jacob et al. have tried to shed light through allometric scaling of basic
information about dose conversions between species and estimation of starting dose for
clinical trials [108]. Several authors aimed to expand the knowledge on the metabolic fate
of dietary polyphenols such as sample preparation. This is a challenge since cell matrix
and the hemoglobin content may have a significant influence. In this sense, Mülek and
Högger established an efficient method for the quantification of selected polyphenols in
human blood cells by modifying the principles of the QuEChERS approach, which also give
valuable information about the in vivo distribution of bioactive polyphenols metabolites
produced by gut microbiota [94].
It is well known that different bioactive compounds can undergo important trans-
formations during their metabolization before reaching the target tissues. For example,
these compounds may first be hydrolysed by gastric juice in the stomach. They can
also be metabolized by intestinal cell enzymes or catabolized by the colonic microbiota,
which can drastically affect the absorption of these molecules through the gut barrier.
In fact, it is quite common that the corresponding aglycones compounds are generated
through enzymatic hydrolysis reactions. Dietary phenolic compounds can also undergo
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phase II metabolism reactions in the small intestine by enzymes such as β-glucosidases,
UDP-glucuronosyltransferase or catechol-O-methyltransferase. Additionally, once the
compounds or derived metabolites have passed into the bloodstream, they may continue
to undergo phase I and II metabolic reactions in the liver, such as oxidation-reduction,
methylation, sulfation or glucuronidation reactions [109–111]. The detection of possible
derivative metabolites in biological samples has been possible thanks to the advances of
high-resolution analytical techniques and the field of metabolomics. For instance, Achour
et al. recently identified phase II metabolites from rosemary in plasma and urine samples
using a targeted metabolomic approach based on HPLC–MS–QTOF [112]. In another study,
Gómez-Juaristi et al. used a similar methodology to identify phase II metabolites from
cocoa in a dietary intervention carried out in healthy humans [113].
Moreover, recent studies in human about pharmacokinetic profiles of different polyphe-
nols provide valuable information to design future clinical interventions studies. This is
crucial above all compounds with extensive degradation and metabolism. In this scenario,
de Ferrars et al. have used a 13C-labelled anthocyanin and isotope-ratio MS in order to
study the absorption and metabolism of these compounds. In this study, 17 circulating
blood metabolites were detected and, on the other hand, 31 and 28 metabolites were found
in the urine and feces, respectively [98]. However, the major limitation of this analytical
methodology was the high number of compounds that were not identified (unknowns).
For this reason, additional synthesis of the speculated metabolites or alternative analytical
techniques such as GC–MS/MS and HPLC–TOF–MS would enable to identify further
metabolites not captured by this methodology [98].
3.2. Longitudinal Intervention Studies
Longitudinal nutritional intervention studies are based on the observation and detec-
tion of physiological changes due to prolonged intake, for weeks or months, of a given
daily dose of a food, compound, extract or diet. These types of trials can be applied with
different objectives, such as studying the influence that a certain diet has on the risk factors
of different pathologies (e.g., cardiovascular diseases, diabetes, cancer, etc.) [114]; or deter-
mining the impact of the consumption of certain foods, bioactive compounds or nutrients
on the metabolic pathways [115,116]. Numerous longitudinal studies have been performed
focused on anthropometric measurements (weight, height, waist and hip circumference) or
in simple measurements in blood such as fasting blood glucose, insulin sensitivity or global
lipid profiles (triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density
lipoprotein cholesterol (HDL-C) or total cholesterol (TC)) [117,118].
In the same way as acute intervention studies, the longitudinal studies can be carried
out in both animal and human models, where biological samples are usually collected at
the beginning and at the end of the clinical trial for the identification of altered endogenous
metabolites after nutritional intervention (Figure 2). Participants must be selected through
previously established inclusion and exclusion criteria, since numerous factors can affect
the results of the study, such as age, gender, lifestyle, health status, status metabolic,
etc. To verify the results obtained and guarantee their quality, the use of randomized
double-blind studies is required through the use of control groups that consume a placebo
diet, in which participants do not know their membership in the assigned experimental
group [91].
Unlike acute intervention studies, the use of high-resolution techniques in this type
of study is focused on knowing the alterations produced in endogenous metabolites
due to intake instead of detecting the original compounds or their related metabolites in
biological samples. In this context, the emergence in the last decade of the metabolomics
field and the high-resolution analytical techniques, has allowed the application of these
tools in longitudinal nutritional intervention assays in order to know the impact on the
endogenous metabolic pathways produced by a certain intake. For longitudinal nutritional
studies, these analytical techniques are typically applied within the workflow of targeted
and untargeted metabolomic strategies. Targeted strategies focus on evaluating how
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the intake of a certain potential bioactive ingredient or functional food affects specific
metabolic pathways. The selection of the target metabolites or metabolic pathways is
normally related to the beneficial effects that are intended to be demonstrated or based on
commercial kits [91,119].
Figure 2. Scheme of a typical longitudinal intervention study carried out in humans.
The metabolomic untargeted strategies are based on detecting the greatest possible
number of meaningful signals in the biological samples. It is important to note that no tech-
nique is able to analyze the entire metabolome. For instance, in LC–ESI–MS, reverse phase
(RP) mode allows to separate semipolar compounds such as lipids, vitamins, alkaloids,
glycosylated steroids and other glycosylated species. On the other hand, hydrophilic inter-
action chromatography (HILIC), which is gaining popularity in recent years, is capable of
separating the most polar compounds such as sugars, amino sugars, amino acids, vitamins,
carboxylic acids or nucleotides, among others [120]. Regarding GC–MS, this hyphenated
technique is used for the analyses of low molecular weight volatile metabolites, and non-
volatiles after derivatization steps (amino acids, organic acids, sugars, amines, alcohols,
amides) [121].
Despite the lower sensitivity of NMR compared to MS, NMR is also being applied
in metabolomic studies in recent years. This technique has multiple advantages such as
its non-destructive, nonbiased, high reproducibility, little sample treatment and greater
capacity for large-scale metabolomic studies. In addition to these advantages, NMR is
especially sensitive to analyzing compounds that are more difficult to detect with LC–MS,
such as alcohols, organic acids, sugars, polyols, and other highly polar compounds. [122].
The majority of longitudinal nutritional intervention studies has been highly applied
using foods that are consumed daily in the diet such as cheese, milk, vitamins, butter
or fish oils, among others [115,123]. Due to the development of new products in recent
years, such as nutraceuticals of functional foods, this type of study is currently being
applied to bioactive compounds, plant extracts or dietary supplements with the aim of
knowing their health effects in the metabolism after its prolonged intake [116,124]. Table 3
lists a representative number of longitudinal nutritional intervention studies conducted
with metabolomic methodologies. These types of studies have been carried out in order
to detect the metabolic changes produced by an isolated bioactive compound, such as
vitamin E [124], catechin [125] or resveratrol [126]; bioactive extracts (curcuma [127], rose-
mary [128], grape skin [129], etc.); or functional supplements based on garlic [130] or grape
skin polyphenols [116], among others. The different studies carried out with grape extracts
or supplements are a clear example of the complementarity of the different analytical tech-
niques to study the different compound classes of the metabolome due to the fact that these
studies have been conducted using NMR [131], LC–MS [116] or GC–MS [132] techniques.
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Furthermore, these studies can be divided into two types depending on whether a
model of healthy individuals or a specific pathology is used. In this sense, longitudinal
studies have been applied to determine how the consumption of certain bioactive products
affects the metabolism of different pathologies such as metabolic syndrome [126], hyper-
cholesterolemia [133], diabetes [128], irritable bowel syndrome [134] or cardiovascular
diseases [135], among others.
In addition to the importance of the aforementioned analytical techniques, other
steps are required in longitudinal nutritional studied based on untargeted metabolomic
methodologies such as data processing, statistical, metabolite identification and pathway
analysis techniques. Given the high number of signals obtained in the analyses by MS
or NMR, sophisticated data processing techniques must be carried out, encompassing
peak picking, alignment, normalization or annotation techniques, among others [136,137].
Once the data is processed, the statistical techniques are applied to select the variables
that show a significant effect after the intake of the product studied. These techniques are
classified, in univariate analyses (e.g., t-test, ANOVA, fold change, etc.) and multivariate
analyses such as principal component analyses (PCA), partial least squares–discriminant
analysis (PLS-DA), orthogonal projections to latent structures discriminant analysis (OPLS-
DA), random forest (RF) or hierarchical cluster analysis (HCA) [138]. Univariate methods
are characterized by the analysis of each variable individually and independently while
multivariate methods take into account all the variables simultaneously, making it possible
to identify relationships and interactions between the different metabolites [138]. Given
the high number of variables detected in this type of studies, there is a high probability
of finding false negative and/or false positive results in statistical models. Therefore,
the validation of statistical models is a necessary step to verify and guarantee the quality
of the results. In this sense, there are mainly three validation methods: cross-validation
(CV), permutation analyses and external validation. CV methods are based on the division
of the data set into two subsets for use in the construction and validation of the models,
separately. In contrast, the external validation uses a new set of samples for this purpose.
Regarding permutation test, this is used in order to verify that the statistical model does
not present over-fitting. This is based on using the classification model with the classes
randomly assigned. In this way, the results obtained by the original model are statistically
compared with those obtained by means of permutations [139].
Finally, the significant signals obtained in the statistical analyses must be identified
in their corresponding endogenous (or exogenous) metabolites. Whereas NMR has the
potential to assign chemical structures, MS studies presents greater limitations for the
identification of metabolites. In MS studies, GC-EI–MS has greater advantages for identifi-
cation because there are chemical libraries that facilitate the identification of metabolites
by comparison of the fragments obtained after electron ionization. On the other hand,
LC–MS studies needs to perform tandem mass spectrometry analysis (MS/MS) to obtain
characteristic fragments of the metabolites to be compared with the information available
in different databases, such as HMDB, KEGG, LipidMaps or METLIN [140]. In spite of
these tools, the identification step remains a bottleneck in untargeted metabolomic studies
based on MS since many of the signals cannot be correctly identified [141].
The application of metabolomics and analytical techniques in longitudinal intervention
studies provides knowledge about the effects of prolonged ingestion of a compound with
potential bioactivity on metabolism. This knowledge can be essential to better understand
the bioactive effects and have more information to support the use of these compounds
for the development of functional foods. Despite this potential application of analytical
techniques and untargeted metabolomics in longitudinal intervention studies, there are still
not many studies carried out with functional foods. Therefore, this type of study may have
great potential for development in the coming years in the field of functional food research.
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Table 3. Application of analytical approaches in longitudinal nutritional studies.
Bioactive Compound, Extract
or Supplement Analytical Technique Biological Samples Population Dose/Intervention Results Ref
Catechin LC(RP)-QTOF–MS Plasma, urine, heart, liverand aorta
24 male Wistar rats divided in
different groups
Diet supplemented or not with 0.2%
(+)-catechin.
76 variables affected by catechin
supplementation [125]
Resveratrol UPLC(RP)-Orbitrap–MS/MSGC-EI-Q–MS
Blood, urine, adipose tissue,
skeletal muscle tissue
66 men subjects with
metabolic syndrome
(a) 75 mg twice daily
(b) 500 mg twice daily
(c) Placebo
Duration: 4 months
Reduced sulphated androgen precursors,
long-chain PUFAs (n-3 and n-6) increased in
adipose tissue,
[126]
Vitamin E LC(RP)–MS(QTOF) Plasma samples 10 male adults 400 mg/d of RRR-α-tocopherylacetate (4 weeks)
Influence in phospholipid metabolism and
lysoPC generation [124]
Cocoa
(Theobroma cacao L.) LC(RP)-QQQ–MS/MS
24 h urine and fasting
plasma samples
19 men and 23 women
presenting high risk of
cardiovascular heart disease
(a) 20 g/day of cocoa powder
with 250 mL skimmed milk
(b) Placebo (500 mL/day of
skimmed milk)
Duration: 4 weeks
Increase in the urinary excretion of colonic
microbial-derived phenolic metabolites,
and biomarkers of the intake.
[135]
Chamomile extract 1H NMR Urine samples 14 healthy volunteers
5 g of powder in 200 mL of boiling
water (5 times/day). Duration:
2 weeks





GC-ITQ–MS (Fatty acids) Serum samples 30 rats (animal model)
(a) HFS diet with a Curcuma
longa extract.
(b) HFS diet (control)
(c) standard diet
Duration: 10 weeks
Metabolic differences in MUFA, n-3 PUFA,
glycoproteins, glutamine and methanol (fatty
acid metabolism)
[127]
Rosemary extract LC(RP)-QTOF–MS Urine samples 30 streptozotocin-induceddiabetic rats
R.officinalis (150 mg) plus folic acid
(15 mg)
Several amino acids and their metabolites
point to changes due to the effect of
the gut microbiota
[128]
Soy GC-Q–MS Fecal samples 35 female rats
SOY diet (590 mg/kg od soy
isoflavones) or placebo.
Duration: 29 weeks
SOY-fed animals had greater fecal
concentrations of the beneficial bacterial
metabolite, S-equol
[143]
Soy beef and grapefruit
juice
1H NMR Serum samples 25 healthy male volunteers
140 g of soy bean beefs and 500 mL
of grapefruit juice per day for four
consecutive days
Decrease of lactate, cholesterols and
triglycerides [131]
Probiotic fermented milk 1H NMR Serum and fecal samples 74 patients with irritable bowelsyndrome
Probiotic fermented milk (150 mL)
or placebo
3/times daily for 8 weeks
Dysregulation in energy




polyphenols from wine and
red grape
GC-TOF–MS Blood, 24 h urine,and fecal samples 26 adult human volunteers
Cellulose capsules with a
polyphenol-rich mix of red wine
and red grape juice extracts (800 mg
of polyphenols) or placebo.
Duration: 4 weeks
Increase of phenolic acids and evaluation of
the gut microbial impact [132]
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Table 3. Cont.
Bioactive Compound, Extract
or Supplement Analytical Technique Biological Samples Population Dose/Intervention Results Ref
Functional food based on grape
skin polyphenols LC(RP)-QTOF–MS 24 h urine samples 31 volunteers
187 mL of the functional beverage,
containing a
grape skin extract
Control beverage as a placebo
Duration: 15 days
Presence offirst-stage microbial metabolites
of flavanols
Several epicatechin and phenolic acid
metabolites as markers of the intake
[116]
Red wine and
grape juice extracts (WGM)
GC-Q–MS
LC(RP)-QQQ–MS Urine and plasma samples 35 healthy males
WGM in gelatin capusles (870 mg of
dry weight red wine extract and
540 mg of dry weight grape juice
extract) or placebo. Duration: 5 days
Alteration of microbial protein fermentation






LC(RP)-ESI-QTOF–MS Plasma samples 30 healthy volunteers (15 menand 15 women)
One gelatine capsule contained per





Decrease of four fructosamines
[130]
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4. Conclusions
The rapid evolution of high-resolution analytical techniques such as LC–MS, GC–MS
and RMN, has contributed to an enormous improvement in this field of food science.
These techniques have proven to be fundamental tools at various steps of functional food
development. These have been used in numerous phytochemical characterization studies
as well as in the analysis of biological samples collected in bioavailability, metabolism and
longitudinal intervention studies. The use of analytical platforms is also useful for the
discovery of new biomarkers in the field of food science field and biomedicine, as they offer
detailed and reliable information about the metabolism of bioactive compounds, including
their bioavailability and pharmacokinetics. These results help in a considerable extent
in the functional food or nutraceutical development with bioactive effects in different
disorders. In spite of the high sensitivity of these analytical platforms, further upgrades are
needed to increase the ability to resolve isomers or discern a larger number of metabolites
generated, including those that are below the detection limits. Promising advances in these
techniques, such as the use of IMS coupled to LC–MS, will allow an advance in knowledge
in the field of functional food development in the coming years.
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62. Orhan, N.; Ekin, H.N.; Şüküroglu, M.K.; Aslan, M. In vitro antidiabetic effect, quantitative studies and UPLC-TOF-MS analysis of
black tea samples from Turkish market. J. Res. Pharm. 2019, 23, 484–497. [CrossRef]
63. Li, R.; Chen, Z.; Tao, Y.; Pan, X.; Jiang, D.; Dong, F.; Xu, J.; Liu, X.; Wu, X.; Zheng, Y. Determination of Valifenalate in Grape,
Vegetables, and Soil Using Ultrahigh Performance Liquid Chromatography Tandem Mass Spectrometry and Exploration of Its
Degradation Behavior in Grape Field. Food Anal. Methods 2019, 12, 742–751. [CrossRef]
64. Vallverdú-Queralt, A.; Verbaere, A.; Meudec, E.; Cheynier, V.; Sommerer, N. Straightforward Method To Quantify GSH, GSSG,
GRP, and Hydroxycinnamic Acids in Wines by UPLC-MRM-MS. J. Agric. Food Chem. 2015, 63, 142–149. [CrossRef]
65. Zhang, L.; Tai, Y.; Wang, Y.; Meng, Q.; Yang, Y.; Zhang, S.; Yang, H.; Zhang, Z.; Li, D.; Wan, X. The proposed biosynthesis of
procyanidins by the comparative chemical analysis of five Camellia species using LC-MS. Sci. Rep. 2017, 7, 46131. [CrossRef]
[PubMed]
66. Ni, S.; Qian, D.; Duan, J.; Guo, J.; Shang, E.; Shu, Y.; Xue, C. UPLC–QTOF/MS-based screening and identification of the
constituents and their metabolites in rat plasma and urine after oral administration of Glechoma longituba extract. J. Chromatogr.
B 2010, 878, 2741–2750. [CrossRef]
67. Phan, A.D.T.; Netzel, G.; Chhim, P.; Netzel, M.E.; Sultanbawa, Y. Phytochemical Characteristics and Antimicrobial Activity of
Australian Grown Garlic (Allium Sativum L.) Cultivars. Foods 2019, 8, 358. [CrossRef]
68. Md Yusof, A.; Abd Gani, S.; Zaidan, U.; Halmi, M.; Zainudin, B. Optimization of an Ultrasound-Assisted Extraction Condition for
Flavonoid Compounds from Cocoa Shells (Theobroma cacao) Using Response Surface Methodology. Molecules 2019, 24, 711.
[CrossRef]
69. Pérez-Mendoza, M.B.; Llorens-Escobar, L.; Vanegas-Espinoza, P.E.; Cifuentes, A.; Ibáñez, E.; Villar-Martínez, A.A. Del Chemical
characterization of leaves and calli extracts of Rosmarinus officinalis by UHPLC-MS. Electrophoresis 2019, 41, 1776–1783. [CrossRef]
70. Wang, Y.; Kan, Z.; Wan, X.; McGinley, J.N.; Thompson, H.J. Differences in chemical composition predictive of in vitro biological
activity among commercially important cultivars of genus Camellia. Food Chem. 2019, 297, 124950. [CrossRef] [PubMed]
71. Di Stefano, V.; Pitonzo, R.; Novara, M.E.; Bongiorno, D.; Indelicato, S.; Gentile, C.; Avellone, G.; Bognanni, R.; Scandurra, S.;
Melilli, M.G. Antioxidant activity and phenolic composition in pomegranate (Punica granatum L.) genotypes from south Italy by
UHPLC-Orbitrap-MS approach. J. Sci. Food Agric. 2019, 99, 1038–1045. [CrossRef]
72. Gabaston, J.; Leborgne, C.; Waffo-Teguo, P.; Valls, J.; Palos Pinto, A.; Richard, T.; Cluzet, S.; Mérillon, J. Wood and roots of major
grapevine cultivars and rootstocks: A comparative analysis of stilbenes by UHPLC-DAD-MS/MS and NMR. Phytochem. Anal.
2019, 30, 320–331. [CrossRef]
73. Minoja, A.P.; Napoli, C. NMR screening in the quality control of food and nutraceuticals. Food Res. Int. 2014, 63, 126–131.
[CrossRef]
74. Marcone, M.F.; Wang, S.; Albabish, W.; Nie, S.; Somnarain, D.; Hill, A. Diverse food-based applications of nuclear magnetic
resonance (NMR) technology. Food Res. Int. 2013, 51, 729–747. [CrossRef]
75. Laghi, L.; Picone, G.; Capozzi, F. Nuclear magnetic resonance for foodomics beyond food analysis. TrAC Trends Anal. Chem. 2014,
59, 93–102. [CrossRef]
76. Christophoridou, S.; Dais, P. Detection and quantification of phenolic compounds in olive oil by high resolution 1H nuclear
magnetic resonance spectroscopy. Anal. Chim. Acta 2009, 633, 283–292. [CrossRef] [PubMed]
77. Manjunatha Reddy, G.N.; Mannina, L.; Sobolev, A.P.; Caldarelli, S. Polyphenols Fingerprinting in Olive Oils Through Maximum-
Quantum NMR Spectroscopy. Food Anal. Methods 2018, 11, 1012–1020. [CrossRef]
78. Liang, T.; Wei, F.; Lu, Y.; Kodani, Y.; Nakada, M.; Miyakawa, T.; Tanokura, M. Comprehensive NMR analysis of compositional
changes of black garlic during thermal processing. J. Agric. Food Chem. 2015, 63, 683–691. [CrossRef]
79. Lee, J.E.; Lee, B.J.; Chung, J.O.; Shin, H.J.; Lee, S.J.; Lee, C.H.; Hong, Y.S. 1H NMR-based metabolomic characterization during
green tea (Camellia sinensis) fermentation. Food Res. Int. 2011, 44, 597–604. [CrossRef]
Int. J. Mol. Sci. 2021, 22, 3220 18 of 20
80. Caruso, M.; Galgano, F.; Castiglione Morelli, M.A.; Viggiani, L.; Lencioni, L.; Giussani, B.; Favati, F. Chemical profile of white wines
produced from “Greco bianco” grape variety in different Italian areas by nuclear magnetic resonance (NMR) and conventional
physicochemical analyses. J. Agric. Food Chem. 2012, 60, 7–15. [CrossRef] [PubMed]
81. Jallali, I.; Waffo Téguo, P.; Smaoui, A.; Mérillon, J.M.; Abdelly, C.; Ksouri, R. Bio-guided fractionation and characterization of
powerful antioxidant compounds from the halophyte Inula crithmoїdes. Arab. J. Chem. 2018. [CrossRef]
82. Alegbe, E.O.; Teralı, K.; Olofinsan, K.A.; Surgun, S.; Ogbaga, C.C.; Ajiboye, T.O. Antidiabetic activity-guided isolation of gallic
and protocatechuic acids from Hibiscus sabdariffa calyxes. J. Food Biochem. 2019, 43, 1–12. [CrossRef] [PubMed]
83. Degenhardt, A.; Knapp, H.; Winterhalter, P. Separation and purification of anthocyanins by high-speed countercurrent chro-
matography and screening for antioxidant activity. J. Agric. Food Chem. 2000, 48, 338–343. [CrossRef]
84. Grajeda-Iglesias, C.; Figueroa-Espinoza, M.C.; Barouh, N.; Baréa, B.; Fernandes, A.; De Freitas, V.; Salas, E. Isolation and
Characterization of Anthocyanins from Hibiscus sabdariffa Flowers. J. Nat. Prod. 2016, 79, 1709–1718. [CrossRef]
85. Moraes, V.R.S.; Thomasi, S.S.; Sprenger, R.F.; Prado, V.M.J.; Cruz, E.M.O.; Cass, Q.B.; Ferreira, A.G.; Blank, A.F. Secondary
metabolites from an infusion of Lippia gracilis schauer using the LC-DAD-SPE/NMR hyphenation technique. J. Braz. Chem. Soc.
2017, 28, 1335–1340. [CrossRef]
86. Li, L.; Zhang, S.; Cui, Y.; Li, Y.; Luo, L.; Zhou, P.; Sun, B. Preparative separation of cacao bean procyanidins by high-speed
counter-current chromatography. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2016, 1036–1037, 10–19. [CrossRef]
87. Ma, W.; Waffo-Téguo, P.; Jourdes, M.; Li, H.; Teissedre, P.L. First evidence of epicatechin vanillate in grape seed and red wine.
Food Chem. 2018, 259, 304–310. [CrossRef] [PubMed]
88. Zhang, Y.; Adelakun, T.A.; Qu, L.; Li, X.; Li, J.; Han, L.; Wang, T. New terpenoid glycosides obtained from Rosmarinus officinalis L.
aerial parts. Fitoterapia 2014, 99, 78–85. [CrossRef]
89. Ahmed, A.F.; Al-Yousef, H.M.; Al-Qahtani, J.H.; Al-Said, M.S. A hepatonephro-protective phenolic-rich extract from red onion
(Allium cepa L.) peels. Pak. J. Pharm. Sci. 2017, 30, 1971–1979. [PubMed]
90. Hu, M.; Wu, B.; Liu, Z. Bioavailability of Polyphenols and Flavonoids in the Era of Precision Medicine. Mol. Pharm. 2017, 14,
2861–2863. [CrossRef]
91. Ulaszewska, M.M.; Weinert, C.H.; Trimigno, A.; Portmann, R.; Andres Lacueva, C.; Badertscher, R.; Brennan, L.; Brunius, C.; Bub,
A.; Capozzi, F.; et al. Nutrimetabolomics: An Integrative Action for Metabolomic Analyses in Human Nutritional Studies. Mol.
Nutr. Food Res. 2019, 63, 1800384. [CrossRef]
92. Velderrain-Rodríguez, G.R.; Palafox-Carlos, H.; Wall-Medrano, A.; Ayala-Zavala, J.F.; Chen, C.-Y.O.; Robles-Sánchez, M.;
Astiazaran-García, H.; Alvarez-Parrilla, E.; González-Aguilar, G.A. Phenolic compounds: Their journey after intake. Food Funct.
2014, 5, 189–197. [CrossRef]
93. Dima, C.; Assadpour, E.; Dima, S.; Jafari, S.M. Bioavailability and bioaccessibility of food bioactive compounds; overview and
assessment by in vitro methods. Compr. Rev. Food Sci. Food Saf. 2020, 19, 2862–2884. [CrossRef]
94. Mülek, M.; Högger, P. Highly sensitive analysis of polyphenols and their metabolites in human blood cells using dispersive SPE
extraction and LC-MS/MS. Anal. Bioanal. Chem. 2015, 407, 1885–1899. [CrossRef]
95. Zhang, L.; Han, Y.; Shan, J.; Liang, Y.; Xu, L.; Zhang, S.; Li, J.; Wan, X. Simultaneous determination of seven catechins in rat
plasma by ultra-high performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetics
study. Anal. Methods 2015, 7, 9415–9420. [CrossRef]
96. Tao, Y.; Xu, X.; Yan, J.; Cai, B. A sensitive UPLC–MS/MS method for simultaneous determination of polyphenols in rat plasma:
Application to a pharmacokinetic study of dispensing granules and standard decoction of Cinnamomum cassia twigs. Biomed.
Chromatogr. 2019, 33, 1–8. [CrossRef] [PubMed]
97. Chen, T.Y.; Ferruzzi, M.G.; Wu, Q.L.; Simon, J.E.; Talcott, S.T.; Wang, J.; Ho, L.; Todd, G.; Cooper, B.; Pasinetti, G.M.; et al. Influence
of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the
Zucker diabetic fatty rat. Mol. Nutr. Food Res. 2017, 61, 1–13. [CrossRef]
98. De Ferrars, R.M.; Czank, C.; Zhang, Q.; Botting, N.P.; Kroon, P.A.; Cassidy, A.; Kay, C.D. The pharmacokinetics of anthocyanins
and their metabolites in humans. Br. J. Pharmacol. 2014, 171, 3268–3282. [CrossRef]
99. Chen, W.; Yeo, S.C.M.; Elhennawy, M.G.A.A.; Lin, H.-S. Oxyresveratrol: A bioavailable dietary polyphenol. J. Funct. Foods 2016,
22, 122–131. [CrossRef]
100. Zeng, X.; Su, W.; Zheng, Y.; He, Y.; He, Y.; Rao, H.; Peng, W.; Yao, H. Pharmacokinetics, Tissue Distribution, Metabolism,
and Excretion of Naringin in Aged Rats. Front. Pharmacol. 2019, 10, 1–12. [CrossRef] [PubMed]
101. Wang, J.; Li, G.; Rui, T.; Kang, A.; Li, G.; Fu, T.; Li, J.; Di, L.; Cai, B. Pharmacokinetics of rosmarinic acid in rats by LC-MS/MS:
Absolute bioavailability and dose proportionality. RSC Adv. 2017, 7, 9057–9063. [CrossRef]
102. López de las Hazas, M.-C.; Rubió, L.; Kotronoulas, A.; De la Torre, R.; Solà, R.; Motilva, M.-J. Dose effect on the uptake and
accumulation of hydroxytyrosol and its metabolites in target tissues in rats. Mol. Nutr. Food Res. 2015, 59, 1395–1399. [CrossRef]
103. Ye, W.; Chen, R.; Sun, W.; Huang, C.; Lin, X.; Dong, Y.; Wen, C.; Wang, X. Determination and pharmacokinetics of engeletin in rat
plasma by ultra-high performance liquid chromatography with tandem mass spectrometry. J. Chromatogr. B 2017, 1060, 144–149.
[CrossRef] [PubMed]
104. Zhang, C.; Ma, W.; Zhang, Y.; Wang, Q.; Qin, C.; Du, S.; Huang, L.; Ye, F.; Chen, L.; Zheng, T. Pharmacokinetics, Bioavailability,
and Tissue Distribution Study of Angoroside C and Its Metabolite Ferulic Acid in Rat Using UPLC-MS/MS. Front. Pharmacol.
2018, 9, 1186. [CrossRef]
Int. J. Mol. Sci. 2021, 22, 3220 19 of 20
105. Wang, C.; Li, Q.; Han, G.; Zou, L.; Lv, L.; Zhou, Q.; Li, N. LC-MS / MS for Simultaneous Determination of Four Major Active
Catechins of Tea Polyphenols in Rat Plasma and Its Application to Pharmacokinetics. Chinese Herb. Med. 2010, 2, 289–296.
106. Tresserra-Rimbau, A.; Lamuela-Raventos, R.M.; Moreno, J.J. Polyphenols, food and pharma. Current knowledge and directions
for future research. Biochem. Pharmacol. 2018, 156, 186–195. [CrossRef] [PubMed]
107. Chang, H.-Y.; Hsueh, T.Y.; Tsai, T.-H. Monitoring of polyphenol mangiferin by liquid chromatography tandem mass spectrometry
in rat and its comparative pharmacokinetic study of a single compound, a single botanic extract and multiple botanic extract. Sep.
Sci. Plus 2018, 1, 603–618. [CrossRef]
108. Nair, A.; Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 2016, 7, 27.
[CrossRef]
109. Bohn, T. Dietary factors affecting polyphenol bioavailability. Nutr. Rev. 2014, 72, 429–452. [CrossRef]
110. Scalbert, A.; Williamson, G. Dietary Intake and Bioavailability of Polyphenols. Proc. J. Nutr. 2000, 3, 121–125. [CrossRef]
111. Scalbert, A.; Morand, C.; Manach, C.; Rémésy, C. Absorption and metabolism of polyphenols in the gut and impact on health.
Biomed. Pharmacother. 2002, 56, 276–282. [CrossRef]
112. Achour, M.; Bravo, L.; Sarriá, B.; Ben Fredj, M.; Nouira, M.; Mtiraoui, A.; Saguem, S.; Mateos, R. Bioavailability and nutrikinetics
of rosemary tea phenolic compounds in humans. Food Res. Int. 2021, 139, 109815. [CrossRef] [PubMed]
113. Gómez-Juaristi, M.; Sarria, B.; Martínez-López, S.; Clemente, L.B.; Mateos, R. Flavanol bioavailability in two cocoa products with
different phenolic content. A comparative study in humans. Nutrients 2019, 11, 1441. [CrossRef]
114. Salas-Salvadó, J.; Bulló, M.; Babio, N.; Martínez-González, M.Á.; Ibarrola-Jurado, N.; Basora, J.; Estruch, R.; Covas, M.I.; Corella,
D.; Arós, F.; et al. Reduction in the incidence of type 2 diabetes with the Mediterranean diet: Results of the PREDIMED-Reus
nutrition intervention randomized trial. Diabetes Care 2011, 34, 14–19. [CrossRef]
115. Zheng, H.; Clausen, M.R.; Dalsgaard, T.K.; Bertram, H.C. Metabolomics to explore impact of dairy intake. Nutrients 2015, 7,
4875–4896. [CrossRef]
116. Khymenets, O.; Andres-Lacueva, C.; Urpi-Sarda, M.; Vazquez-Fresno, R.; Mart, M.M.; Reglero, G.; Torres, M.; Llorach, R.
Metabolic fingerprint after acute and under sustained consumption of a functional beverage based on grape skin extract in
healthy human subjects. Food Funct. 2015, 6, 1288–1298. [CrossRef]
117. Panahi, Y.; Khalili, N.; Hosseini, M.S.; Abbasinazari, M.; Sahebkar, A. Lipid-modifying effects of adjunctive therapy with
curcuminoids-piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial. Complement.
Ther. Med. 2014, 22, 851–857. [CrossRef] [PubMed]
118. Venturini, D.; Simão, A.N.C.; Urbano, M.R.; Dichi, I. Effects of extra virgin olive oil and fish oil on lipid profile and oxidative
stress in patients with metabolic syndrome. Nutrition 2015, 31, 834–840. [CrossRef] [PubMed]
119. Guasch-Ferré, M.; Bhupathiraju, S.N.; Hu, F.B. Use of Metabolomics in Improving Assessment of Dietary Intake. Clin. Chem. 2018,
64, 82–98. [CrossRef] [PubMed]
120. Zhou, B.; Feng Xiao, J.; Tuli, L.; Ressom, H.W. LC-MS-based metabolomics. Mol. BioSyst. 2012, 8, 470–481. [CrossRef]
121. Koek, M.M.; Jellema, R.H.; Van der Greef, J.; Tas, A.C.; Hankemeier, T. Quantitative metabolomics based on gas chromatography
mass spectrometry: Status and perspectives. Metabolomics 2011, 7, 307–328. [CrossRef]
122. Emwas, A.-H.; Roy, R.; McKay, R.T.; Tenori, L.; Saccenti, E.; Gowda, G.A.N.; Raftery, D.; Alahmari, F.; Jaremko, L.; Jaremko, M.;
et al. NMR Spectroscopy for Metabolomics Research. Metabolites 2019, 9, 123. [CrossRef] [PubMed]
123. Brennan, L. Metabolomics in nutrition research: Current status and perspectives. Biochem. Soc. Trans. 2013, 41, 670–673. [CrossRef]
124. Wong, M.; Lodge, J.K. A metabolomic investigation of the effects of vitamin E supplementation in humans. Nutr. Metab. (Lond).
2012, 9, 110. [CrossRef]
125. Fardet, A.; Llorach, R.; Martin, J.F.; Besson, C.; Lyan, B.; Pujos-Guillot, E.; Scalbert, A. A liquid chromatography-quadrupole
time-of-flight (LC-QTOF)-Based metabolomic approach reveals new metabolic effects of catechin in rats fed high-fat diets. J.
Proteome Res. 2008, 7, 2388–2398. [CrossRef]
126. Korsholm, A.S.; Kjær, T.N.; Ornstrup, M.J.; Pedersen, S.B. Comprehensive metabolomic analysis in blood, urine, fat, and muscle
in men with metabolic syndrome: A randomized, placebo-controlled clinical trial on the effects of resveratrol after four months’
treatment. Int. J. Mol. Sci. 2017, 18, 554. [CrossRef] [PubMed]
127. Tranchida, F.; Shintu, L.; Rakotoniaina, Z.; Tchiakpe, L.; Deyris, V.; Hiol, A.; Caldarelli, S. Metabolomic and lipidomic analysis of
serum samples following Curcuma longa extract supplementation in high-fructose and saturated fat fed rats. PLoS One 2015, 10,
1–19. [CrossRef] [PubMed]
128. Godzien, J.; Ciborowski, M.; Angulo, S.; Ruperez, F.J.; Martínez, M.P.; Señorans, F.J.; Cifuentes, A.; Ibañez, E.; Barbas, C.
Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats. J. Proteome Res.
2011, 10, 837–844. [CrossRef] [PubMed]
129. Jacobs, D.M.; Fuhrmann, J.C.; Van Dorsten, F.A.; Rein, D.; Peters, S.; Van Velzen, E.J.J.; Hollebrands, B.; Draijer, R.; Van Duynhoven,
J.; Garczarek, U. Impact of short-term intake of red wine and grape polyphenol extract on the human metabolome. J. Agric.
Food Chem. 2012, 60, 3078–3085. [CrossRef] [PubMed]
130. Fernández-Ochoa, Á.; Borrás-Linares, I.; Baños, A.; García-López, J.D.; Guillamón, E.; Nuñez-Lechado, C.; Quirantes-Piné, R.;
Segura-Carretero, A. A fingerprinting metabolomic approach reveals deregulation of endogenous metabolites after the intake of
a bioactive garlic supplement. J. Funct. Foods 2018, 49, 137–145. [CrossRef]
Int. J. Mol. Sci. 2021, 22, 3220 20 of 20
131. Lundstedt, T.; Hedenström, M.; Soeria-Atmadja, D.; Hammerling, U.; Gabrielsson, J.; Olsson, J.; Trygg, J. Dynamic modelling of
time series data in nutritional metabonomics - A powerful complement to randomized clinical trials in functional food studies.
Chemom. Intell. Lab. Syst. 2010, 104, 112–120. [CrossRef]
132. Grün, C.H.; Van Dorsten, F.A.; Jacobs, D.M.; Le Belleguic, M.; Van Velzen, E.J.J.; Bingham, M.O.; Janssen, H.G.; Van Duynhoven,
J.P.M. GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro
intervention studies. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 871, 212–219. [CrossRef]
133. González-Peña, D.; Dudzik, D.; García, A.; De Ancos, B.; Barbas, C.; Sánchez-Moreno, C. Metabolomic fingerprinting in the
comprehensive study of liver changes associated with onion supplementation in hypercholesterolemic Wistar rats. Int. J. Mol. Sci.
2017, 18, 267. [CrossRef]
134. Hong, Y.S.; Hong, K.S.; Park, M.H.; Ahn, Y.T.; Lee, J.H.; Huh, C.S.; Lee, J.; Kim, I.K.; Hwang, G.S.; Kim, J.S. Metabonomic
understanding of probiotic effects in humans with irritable bowel syndrome. J. Clin. Gastroenterol. 2011, 45, 415–425. [CrossRef]
135. Urpi-Sarda, M.; Monagas, M.; Khan, N.; Llorach, R.; Lamuela-Raventós, R.M.; Jáuregui, O.; Estruch, R.; Izquierdo-Pulido, M.;
Andrés-Lacueva, C. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid
chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258–7267. [CrossRef] [PubMed]
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